Medication Safety

Using potassium permanganate for skin conditions or wound care

4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.

Developing opioid safety across a system

26 March 2025Strategies and signposting to support safer use of opioids for chronic, non-cancer pain.

Worked example of assessing the risk of transcribing

28 January 2025Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.

Risk assessing transcribing for administration

28 January 2025Various factors affect the risks associated with using transcribing for medicines administration.

Supporting safe use of adrenal crisis emergency management kits

18 November 2024Treatment of adrenal crisis is time critical and relies on timely use of injectable hydrocortisone to prevent harm.

MSATS - Safe Use of DOACs

30 October 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of DOACs; inspiring partnership across the system.

Managing the risk of confusion between injectable penicillin salts

4 October 2024Minimising the risk of confusion between injectable benzylpenicillin salt formulations may prevent harms.

Safe management of therapeutic drug monitoring

2 October 2024Organisations must ensure safe management systems are in place to support the management of drugs requiring therapeutic drug monitoring.

Managing risks associated with oxytocin infusions during labour

24 September 2024Safety strategies can minimise the risk of harms related to oxytocin infusion overdose and delayed therapy.

Assessing injectables for enteral administration

13 August 2024Clinical decisions on the use of injectable formulations for enteral administration should be guided by safety and practicality.